The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial
Open accessAbstract
BACKGROUND: Meta-analyses of previous randomised controlled trials concluded that the smooth muscle relaxant drugs tamsulosin and nifedipine assisted stone passage for people managed expectantly for ureteric colic, but emphasised the need for high-quality trials with wide inclusion criteria. We aimed to fulfil this need by testing effectiveness of these drugs in a standard clinical care setting. METHODS: For this multicentre, randomised, placebo-controlled trial, we recruited adults (aged 18-65 years) undergoing expectant management for a single ureteric stone identified by CT at 24 UK hospitals. Participants were randomly assigned by a remote randomisation system to tamsulosin 400 μg, nifedipine 30 mg, or placebo taken daily for up to 4 weeks, using an algorithm with centre, stone size (≤5 mm or >5 mm), and stone location (upper, mid, or lower ureter) as minimisation covariates. Participants, clinicians, and trial personnel were masked to treatment assignment. The primary outcome was the proportion of participants who did not need further intervention for stone clearance within 4 weeks of randomisation, analysed in a modified intention-to-treat population defined as all eligible patients for whom we had primary outcome data. This trial is registered with the European Clinical Trials Database, EudraCT number 2010-019469-26, and as an International Standard Randomised Controlled Trial, number 69423238. FINDINGS: Between Jan 11, 2011, and Dec 20, 2013, we randomly assigned 1167 participants, 1136 (97%) of whom were included in the primary analysis (17 were excluded because of ineligibility and 14 participants were lost to follow-up). 303 (80%) of 379 participants in the placebo group did not need further intervention by 4 weeks, compared with 307 (81%) of 378 in the tamsulosin group (adjusted risk difference 1·3% [95% CI -5·7 to 8·3]; p=0·73) and 304 (80%) of 379 in the nifedipine group (0·5% [-5·6 to 6·5]; p=0·88). No difference was noted between active treatment and placebo (p=0·78), or between tamsulosin and nifedipine (p=0·77). Serious adverse events were reported in three participants in the nifedipine group (one had right loin pain, diarrhoea, and vomiting; one had malaise, headache, and chest pain; and one had severe chest pain, difficulty breathing, and left arm pain) and in one participant in the placebo group (headache, dizziness, lightheadedness, and chronic abdominal pain). INTERPRETATION: Tamsulosin 400 μg and nifedipine 30 mg are not effective at decreasing the need for further treatment to achieve stone clearance in 4 weeks for patients with expectantly managed ureteric colic. FUNDING: UK National Institute for Health Research Health Technology Assessment Programme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines on Urolithiasis<footref rid="foot01">1</footref>
Tiselius, H. G., Ackermann, D., Alken, P., Buck, C., Conort, P., & Gallucci, M. (2001) · European Urology · doi:10.1159/000049803 · Cited by 1,140
Medical therapy to facilitate urinary stone passage: a meta-analysis
Hollingsworth, J. M., Rogers, M. A., Kaufman, S. R., Bradford, T. J., Saint, S., Wei, J. T., & Hollenbeck, B. K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69474-9 · Cited by 519
TIME TO STONE PASSAGE FOR OBSERVED URETERAL CALCULI: A GUIDE FOR PATIENT EDUCATION
MILLER, O. F., & KANE, C. J. (1999) · Journal of Urology · doi:10.1097/00005392-199909010-00014 · Cited by 467
Dechartres, A., Boutron, I., Trinquart, L., Charles, P., & Ravaud, P. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-1-201107050-00006 · Cited by 307
DELLABELLA, M., MILANESE, G., & MUZZONIGRO, G. (2005) · Journal of Urology · doi:10.1097/01.ju.0000161600.54732.86 · Cited by 290
Medical Therapy to Facilitate the Passage of Stones: What Is the Evidence?
Seitz, C., Liatsikos, E., Porpiglia, F., Tiselius, H.-G., & Zwergel, U. (2009) · European Urology · doi:10.1016/j.eururo.2009.06.012 · Cited by 282
Association Between Analytic Strategy and Estimates of Treatment Outcomes in Meta-analyses
Dechartres, A., Altman, D. G., Trinquart, L., Boutron, I., & Ravaud, P. (2014) · JAMA · doi:10.1001/jama.2014.8166 · Cited by 233
Fwu, C.-W., Eggers, P. W., Kimmel, P. L., Kusek, J. W., & Kirkali, Z. (2013) · Kidney International · doi:10.1038/ki.2012.419 · Cited by 221
Alpha-blockers as medical expulsive therapy for ureteral stones
Campschroer, T., Zhu, Y., Duijvesz, D., Grobbee, D. E., & Lock, M. T. W. T. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008509.pub2 · Cited by 187
Sur, R. L., Shore, N. D., L’Esperance, J. O., Knudsen, B. E., Gupta, M., Olsen, S., & Shah, O. D. (2014) · European Urology · doi:10.1016/j.eururo.2014.10.049 · Cited by 96
Cited by
Khan, S. R., Pearle, M. S., Robertson, W. G., Gambaro, G., Canales, B. K., Doizi, S., Traxer, O., & Tiselius, H.-G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.8 · Cited by 1,097
Metadata
- Authors
- Pickard, R., Starr, K., MacLennan, G., Lam, T., Thomas, R., Burr, J., McPherson, G., McDonald, A., Anson, K., N'Dow, J., Burgess, N., Clark, T., Kilonzo, M., Gillies, K., Shearer, K., Boachie, C., Cameron, S., Norrie, J., & McClinton, S.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 386
- Issue
- 9991
- Pages
- 341-349
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2159025450
- Cited by
- 351
- References
- 14
- FWCI
- 43.05
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial. https://app.cochat.ai/papers/10.1016/s0140-6736(15)60933-3
- The paper
- Pickard, R., Starr, K., MacLennan, G., Lam, T., Thomas, R., Burr, J., McPherson, G., McDonald, A., Anson, K., N'Dow, J., Burgess, N., Clark, T., Kilonzo, M., Gillies, K., Shearer, K., Boachie, C., Cameron, S., Norrie, J., & McClinton, S. (2015). Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial. The Lancet. https://doi.org/10.1016/s0140-6736(15)60933-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.